At the same time, Gln withdrawal enhanced the expression and binding of Bcl-2 like protein 11 (BIM) to BCL-2 in MM PCs, sensitizing MM cells towards the BH3-mimetic inhibitor Venetoclax (201). The gene discussed is BCL2; the disease is Miyoshi myopathy.